Dengue, chikungunya and zika virus coinfection: results of the national surveillance during the zika epidemic in Colombia.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 28 3 2020
Statut: ppublish

Résumé

Our objective was to determine the frequency of zika (ZIKV), chikungunya (CHIKV) and dengue (DENV) virus coinfection and describe the mortality cases that occurred during the epidemiologic surveillance of the ZIKV epidemic in Colombia. We analysed all cases of suspected ZIKV infection that were reported to the National Institute of Health (October 2015-December 2016). DENV, CHIKV and ZIKV RNA were detected in serum or tissue samples using polymerase chain reaction assay. Medical records of the fatal cases were reviewed. We identified that 23 871 samples were processed. The frequency of viral agents was 439 (1.84%) for DENV, 257 (1.07%) for CHIKV and 10118 (42.38%) for ZIKV. Thirty-four (0.14%) cases of coinfection were identified. The CHIKV-ZIKV coinfection was present in 28 cases (82.3%), DENV-CHIKV in three (8.8%) and DENV-ZIKV in three (8.8%). Seven (20.6%) coinfection cases were fatal (two DENV-CHIKV cases and five CHIKV-ZIKV cases). Two cases were foetal deaths and the others were related to neurological syndrome and sepsis. In conclusion, the frequency of arbovirus coinfection during epidemic of ZIKV was low, and CHIKV-ZIKV coinfection was the most common. Mortality was high among coinfection patients. The role of each virus in the mortality cases of coinfection warrants further studies.

Identifiants

pubmed: 30869010
pii: S095026881800359X
doi: 10.1017/S095026881800359X
pmc: PMC6518562
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e77

Références

Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Trans R Soc Trop Med Hyg. 1964 Jul;58:335-8
pubmed: 14175744
Presse Med. 2006 Nov;35(11 Pt 1):1656-1658
pubmed: 17086120
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Emerg Infect Dis. 2010 Mar;16(3):418-25
pubmed: 20202416
N Engl J Med. 2012 Apr 12;366(15):1423-32
pubmed: 22494122
Antiviral Res. 2013 Sep;99(3):345-70
pubmed: 23811281
World J Virol. 2012 Feb 12;1(1):11-22
pubmed: 24175207
Infect Genet Evol. 2015 Oct;35:134-41
pubmed: 26247719
BMJ. 2015 Sep 15;351:h4661
pubmed: 26374064
Emerg Infect Dis. 2015 Oct;21(10):1885-6
pubmed: 26401719
Euro Surveill. 2015;20(48):30079
pubmed: 26690898
BMC Infect Dis. 2016 Mar 03;16:84
pubmed: 26936191
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Medicine (Baltimore). 2016 Mar;95(12):e3201
pubmed: 27015222
Euro Surveill. 2016 Jun 2;21(22):
pubmed: 27277216
Clin Microbiol Rev. 2016 Jul;29(3):659-94
pubmed: 27281741
Clin Rheumatol. 2016 Oct;35(10):2381-5
pubmed: 27553387
Clin Infect Dis. 2016 Dec 15;63(12):1584-1590
pubmed: 27578819
Biomedica. 2015 Oct 26;36(0):35-43
pubmed: 27622791
N Engl J Med. 2016 Oct 20;375(16):1513-1523
pubmed: 27705091
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1409-1413
pubmed: 27977645
Lancet Infect Dis. 2017 Mar;17(3):e101-e106
pubmed: 28011234
Emerg Infect Dis. 2017 Jun;23(6):982-984
pubmed: 28296632
J Infect. 2017 Jun;74(6):611-615
pubmed: 28344113
N Engl J Med. 2017 Apr 20;376(16):1591-1593
pubmed: 28402236
Int J Infect Dis. 2018 Jul;72:25-27
pubmed: 29738826

Auteurs

Marcela Mercado-Reyes (M)

Department of Research in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Jorge Acosta-Reyes (J)

Department of Public Health, Health Sciences Division,Universidad del Norte,Barranquilla,Colombia.

Edgar Navarro-Lechuga (E)

Department of Public Health, Health Sciences Division,Universidad del Norte,Barranquilla,Colombia.

Sherill Corchuelo (S)

Department of Network in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Angélica Rico (A)

Department of Network in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Edgar Parra (E)

Department of Network in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Natalia Tolosa (N)

Department of Public Health Surveillance,National Institute of Health,Bogota D.C.,Colombia.

Lissethe Pardo (L)

Department of Network in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Maritza González (M)

Department of Public Health Surveillance,National Institute of Health,Bogota D.C.,Colombia.

Jorge Martìn-Rodriguez-Hernández (J)

Institute of Public Health, Javeriana University,Bogotá D.C.,Colombia.

Luz Karime-Osorio (L)

Department of Network in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Martha Ospina-Martinez (M)

General Director,National Institute of Health,Bogota D.C.,Colombia.

Helena Rodriguez-Perea (H)

Department of Research in Public Health,National Institute of Health,Bogota D.C.,Colombia.

Gaspar Del Rio-Pertuz (G)

Department of Medicine, Health Sciences Division,Universidad del Norte and Hospital Universidad del Norte,Barranquilla,Colombia.

Diego Viasus (D)

Department of Medicine, Health Sciences Division,Universidad del Norte and Hospital Universidad del Norte,Barranquilla,Colombia.

Articles similaires

Humans COVID-19 SARS-CoV-2 Vaccination Pandemics
Musa Colombia Cost-Benefit Analysis Fusarium Plant Diseases
Humans Influenza, Human Forecasting France Computational Biology
Humans Male Adolescent Coinfection Tuberculosis, Pulmonary

Classifications MeSH